PATENT CLAIM ANALYSIS

Application Number: 15908599
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "370000"]

Abstract:
To provide a mirabegron-containing tablet that maintains the amorphous form of mirabegron even after long-term storage. Also, to provide a mirabegron-containing pharmaceutical preparation that can maintain the purity of mirabegron while preventing the generation of related substances at the time of storage, a method for producing a mirabegron-containing pharmaceutical preparation, and a method for producing a mirabegron-containing granulated product. According to an embodiment of the present invention, there is provided a mirabegron-containing pharmaceutical preparation containing mirabegron, hypromellose, and polyvinylpyrrolidone. The mirabegron-containing pharmaceutical preparation may contain a spray-dried granulated product containing the mirabegron, the hypromellose, and the polyvinylpyrrolidone.

Claim (Index 3):
The mirabegron-containing pharmaceutical preparation according to  claim 2 , wherein the spray-dried granulated product contains 100% or more by mass of the hypromellose and the polyvinylpyrrolidone in total with respect to a content of the mirabegron.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 2.0566
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14692070', '15553107', '14117569', '14764663', '15547835']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7692542875497792
- 35 USC 102 Novelty (BERT): 0.496784194205417
- Combined Prediction Score: 0.7420072782153431
- Mean Citation Score: 205.78623
- Max Citation Score: 246.17863
- Similarity Product: 190.00661949911296

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test